Medicure annual stock-based compensation
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Medicure Stock-Based Compensation Growth & History (MCUJF)
Medicure's stock-based compensation was $136,000 for fiscal 2025.
View full Medicure company overviewMedicure annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $136,000 | −$60,000 | −30.61% |
| 2024 | 2024-12-31 | $196,000 | −$92,000 | −31.94% |
| 2023 | 2023-12-31 | $288,000 | $241,000 | +512.77% |
| 2022 | 2022-12-31 | $47,000 | −$88,000 | −65.19% |
| 2021 | 2021-12-31 | $135,000 | −$182,000 | −57.41% |
| 2020 | 2020-12-31 | $317,000 | −$100,000 | −23.98% |
| 2019 | 2019-12-31 | $417,000 | −$605,000 | −59.20% |
| 2018 | 2018-12-31 | $1.0M | $531,000 | +108.15% |
| 2017 | 2017-12-31 | $491,000 | −$849,001 | −63.36% |
| 2016 | 2016-12-31 | $1.3M | −$120,315 | −8.24% |
| 2015 | 2015-12-31 | $1.5M | — | — |
Medicure quarterly stock-based compensation
Q1.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$8,000 | −$38,000 | — |
| Q1 2026 | 2026-03-31 | $3,000 | −$33,000 | −91.67% |
| Q4 2025 | 2025-12-31 | $35,000 | — | — |
| Q3 2025 | 2025-09-30 | $35,000 | — | — |
| Q2 2025 | 2025-06-30 | $30,000 | — | — |
| Q1 2025 | 2025-03-31 | $36,000 | −$22,000 | −37.93% |
| Q1 2024 | 2024-03-31 | $58,000 | — | — |
Medicure stock-based compensation trends
Over the last five fiscal years, Medicure's stock-based compensation decreased from $317,000 to $136,000, a change of −$181,000. The latest reported quarter, Q2 2026, shows −$8,000.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicure source filings ↗